Talkspace (TALK) Stock Price, News & Analysis

Company Overview

Talkspace, Inc. (NASDAQ:TALK) is a digital mental health company that provides online therapy and psychiatry services through a secure, cloud-based platform. Headquartered in New York City, Talkspace enables individuals and couples to connect with licensed therapists and psychiatrists via text messaging, live audio, and video sessions. The company’s platform is accessible through web and mobile applications, allowing clients to seek professional support anytime and from any location with an internet connection.

The company’s core offerings include therapy plans that range from unlimited text-based messaging with a dedicated therapist to scheduled live video sessions. In addition to individual therapy, Talkspace offers couples therapy, teen therapy, and psychiatric care for medication management. Talkspace also produces self-guided mental wellness content, such as exercises, articles, and interactive tools designed to complement one-on-one therapy and provide users with additional coping strategies.

Founded in 2012 by entrepreneurs Oren and Roni Frank, Talkspace was among the early entrants in the digital mental health space. Over the years, the company has expanded its service model to include partnerships with health plans, employers, and wellness platforms, enabling broader access to mental health services for covered members and employees in the United States. In 2021, Talkspace went public via a merger with a special purpose acquisition company (SPAC), marking a significant milestone in its growth trajectory.

Under the leadership of Chief Executive Officer Russell Glass—who joined the company in 2020—Talkspace continues to pursue innovation in teletherapy and digital psychiatry. The management team leverages expertise in technology, healthcare, and behavioral science to enhance the platform’s capabilities and user experience. Today, Talkspace serves clients across all 50 states, with a network of thousands of licensed mental health professionals delivering flexible and scalable care solutions.

Key Stats

• Today's Range: $5.19 to $5.21
• 50-Day Range: $5.17 to $5.23
• 52-Week Range: $2.22 to $5.23
• Volume: 2.70 million shs
• Average Volume: 2.53 million shs
• Market Capitalization: $871.05 million
• P/E Ratio: 520.52
• Dividend Yield: N/A
• Price Target: $5.56
• Consensus Rating: Hold

Talkspace Stock Analysis - MarketRank™

Talkspace scored higher than 48% of companies evaluated by MarketBeat, and ranked 477th out of 852 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.8 / 5
• Analyst Rating: Hold

Consensus Rating

Talkspace has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 7 hold ratings, and 1 sell rating.

Upside/Downside

The consensus price target for Talkspace is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Talkspace has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 69.23%

Earnings Growth

Earnings for Talkspace are expected to grow by 69.23% in the coming year, from $0.13 to $0.22 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Talkspace is 520.52, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 46.31.

Price to Earnings Ratio vs. Sector

The P/E ratio of Talkspace is 520.52, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.02.

Price to Book Value per Share Ratio

Talkspace has a P/B Ratio of 7.32. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.03% of the float of Talkspace has been sold short.

Short Interest Ratio / Days to Cover

Talkspace has a short interest ratio ("days to cover") of 2.15, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Talkspace has recently decreased by 11.83%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Talkspace does not currently pay a dividend.

Dividend Growth

Talkspace does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Talkspace this week, compared to 3 articles on an average week.

MarketBeat Follows

2 people have added Talkspace to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.1 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Talkspace insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $496,803.00 in company stock.

Percentage Held by Insiders

23.50% of the stock of Talkspace is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

57.37% of the stock of Talkspace is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 5/11/2026
• Today: 7/04/2026
• Next Earnings (Estimated): 8/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:TALK
• CIK: 1803901
• Web: www.talkspace.com
• Phone: 212-284-7206
• Fax: N/A
• Employees: 500
• Year Founded: 2011

Price Target and Rating

• Average Price Target for Talkspace: $5.56
• High Price Target: $6.00
• Low Price Target: $5.00
• Potential Upside/Downside: +7.0%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.01
• Trailing P/E Ratio: 520.52
• Forward P/E Ratio: 40.00
• P/E Growth: N/A
• Net Income: $7.79 million
• Net Margins: 0.49%
• Pretax Margin: 0.73%
• Return on Equity: 1.03%
• Return on Assets: 0.88%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.84
• Quick Ratio: 4.84

Sales & Book Value

• Annual Sales: $228.87 million
• Price / Sales: 3.81
• Cash Flow: $0.06 per share
• Price / Cash Flow: 80.75
• Book Value: $0.71 per share
• Price / Book: 7.32

Miscellaneous

• Outstanding Shares: 167,510,000
• Free Float: 128,147,000
• Market Cap: $871.05 million
• Optionable: Optionable
• Beta: 1.07